$424 Million is the total value of Foyston, Gordon, & Payne Inc's 65 reported holdings in Q1 2021. The portfolio turnover from Q4 2020 to Q1 2021 was 27.3% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
PM | Buy | Philip Morris International Inc. | $14,510,000 | +33.0% | 163,517 | +24.1% | 3.42% | +29.9% |
BKNG | Buy | Booking Holdings Inc. | $13,953,000 | +7.0% | 5,989 | +2.3% | 3.29% | +4.5% |
CHRW | Buy | C.H. Robinson Worldwide Inc. | $11,678,000 | +46.6% | 122,369 | +44.2% | 2.75% | +43.2% |
AXP | Buy | American Express | $9,847,000 | +20.9% | 69,618 | +3.3% | 2.32% | +18.0% |
MMC | Buy | Marsh & McLennan Cos. | $8,955,000 | +12.7% | 73,521 | +8.2% | 2.11% | +10.1% |
EFX | Buy | Equifax Inc | $8,110,000 | +86.1% | 44,774 | +98.1% | 1.91% | +81.7% |
UNP | Buy | Union Pacific Corp. | $7,275,000 | +10.7% | 33,008 | +4.6% | 1.72% | +8.1% |
GWW | Buy | W.W. Grainger Inc. | $6,965,000 | +22.2% | 17,372 | +24.4% | 1.64% | +19.3% |
FB | Buy | Facebook Inc - CL A | $6,836,000 | +33.8% | 23,209 | +24.1% | 1.61% | +30.7% |
KEYS | New | Keysight Technologies Inc. | $6,224,000 | – | 43,402 | +100.0% | 1.47% | – |
ROST | Buy | Ross Stores Inc. | $5,705,000 | +65.3% | 47,576 | +69.2% | 1.34% | +61.5% |
AXTA | New | Axalta Coating Systems Ltd. | $2,521,000 | – | 85,240 | +100.0% | 0.59% | – |
SNY | Buy | Sanofi - ADR | $2,105,000 | +8.4% | 42,558 | +6.5% | 0.50% | +5.8% |
CDW | New | CDW Corp. of Delaware | $995,000 | – | 6,000 | +100.0% | 0.24% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-05-14
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
Microsoft Corp. | 42 | Q3 2023 | 10.2% |
Johnson & Johnson | 42 | Q3 2023 | 9.3% |
Mondelez International Inc. | 42 | Q3 2023 | 4.0% |
Coca Cola Co. | 42 | Q3 2023 | 1.7% |
Berkshire Hathaway Inc. CL B | 42 | Q3 2023 | 1.6% |
Becton Dickinson & Co. | 42 | Q3 2023 | 2.7% |
Wal-Mart Stores Inc. | 42 | Q3 2023 | 0.9% |
AbbVie Inc. | 42 | Q3 2023 | 0.5% |
Abbott Laboratories | 42 | Q3 2023 | 0.4% |
Procter & Gamble Co. | 42 | Q3 2023 | 0.2% |
View Foyston, Gordon, & Payne Inc's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Foyston, Gordon, & Payne Inc | September 20, 2012 | 4,798,387 | 4.8% |
Foyston, Gordon, & Payne Inc | April 25, 2012 | 8,966,382 | 9.2% |
TECUMSEH PRODUCTS CO | July 17, 2006 | 553,579 | 4.1% |
CPI CORPSold out | April 27, 2006 | 0 | 0.0% |
View Foyston, Gordon, & Payne Inc's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-05-07 |
13F-HR | 2024-02-07 |
13F-HR | 2023-10-26 |
13F-HR | 2023-08-01 |
13F-HR | 2023-05-03 |
13F-HR | 2023-02-09 |
13F-HR | 2022-11-04 |
13F-HR | 2022-08-11 |
13F-HR | 2022-04-27 |
13F-HR | 2022-02-11 |
View Foyston, Gordon, & Payne Inc's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.